CIK 0001743881 · Large accelerated filer
BridgeBio Pharma, Inc.
Sign in to watch- Ticker
- BBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (650) 391-9740
- Business address
- 3160 PORTER DR., SUITE 250, PALO ALTO, CA, 94304
- Former names
- BridgeBio Pharma LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,563,798
- in 3 filings, $4.6M under 10b5-1 plans
Net −$4,563,798. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-04 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −12,200 | $74.42 | $908K | 4,584,147 |
| 2025-12-04 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −5,700 | $74.80 | $426K | 4,578,447 |
| 2025-11-20 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −6,401 | $64.97 | $416K | 248,531 |
| 2025-11-20 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −14,299 | $65.90 | $942K | 234,232 |
| 2025-11-20 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −5,456 | $66.71 | $364K | 228,776 |
| 2025-11-18 | Lo Andrew Director | Sale | −24,007 | $65.23 | $1.6M | 81,576 |
| 2025-11-18 | Lo Andrew Director | Sale | −30,993 | $66.05 | $2.0M | 50,583 |
| 2025-11-17 | Lo Andrew Director | Sale | −36,801 | $66.63 | $2.5M | 17,887 |
| 2025-11-17 | Lo Andrew Director | Sale | −3,798 | $67.06 | $255K | 14,089 |
| 2025-11-17 | Scott Randal W. Director | Option exercise 10b5-1 | +10,000 | $16.75 | $168K | 21,589 |
| 2025-11-17 | Scott Randal W. Director | Sale 10b5-1 | −3,801 | $66.25 | $252K | 17,788 |
| 2025-11-17 | Scott Randal W. Director | Sale 10b5-1 | −6,199 | $66.89 | $415K | 11,589 |
| 2025-11-17 | Scott Randal W. Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −10,000 | 41,501 | ||
| 2025-11-17 | Trimarchi Thomas President and CFO | Sale 10b5-1 | −9,978 | $66.19 | $660K | 389,786 |
| 2025-11-17 | Trimarchi Thomas President and CFO | Sale 10b5-1 | −6,956 | $66.84 | $465K | 382,830 |
| 2025-11-16 | Kumar Neil Chief Executive Officer | Option exercise | +33,544 | 256,634 | ||
| 2025-11-16 | Kumar Neil Chief Executive Officer | Option exercise | +19,599 | 276,233 | ||
| 2025-11-16 | Kumar Neil Chief Executive Officer | Option exercise | +11,554 | 287,787 | ||
| 2025-11-16 | Kumar Neil Chief Executive Officer | Shares withheld for taxes | −32,855 | $66.39 | $2.2M | 254,932 |
| 2025-11-16 | Kumar Neil Chief Executive Officer | Option exercise · Restricted Stock Units | −33,544 | 167,720 |
Page 12 of 19 · 379 trades